Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02453113 · ClinicalTrials.gov registry record · NA
Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment
A NA study of Vaccine Response Impaired, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT02453113: Completed NA study of Vaccine Response Impaired, sponsored by University of California, Irvine.
NCT02453113 is a NA study of Vaccine Response Impaired that has completed, run by University of California, Irvine. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02453113, a NA study of Vaccine Response Impaired, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.
Primary Outcome
Change in inflammatory cells with low level laser will be measured.
Conditions Studied
Interventions
- OTHER low power laser
Study Locations (2)
California
- Beckman Laser Institute - Irvine
Massachusetts
- Vaccine and Immunotherapy Center Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-01 |
| Phase | NA |
What the finished NCT02453113 record still lists
NCT02453113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Vaccine Response Impaired appearing as the primary indexed condition, and to 1 intervention - of which low power laser is the first listed.
NCT02453113 reports a single indexed study location in California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02453113 about?
NCT02453113 is a clinical study titled "Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment". The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve t...
What is the current status of trial NCT02453113?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-06. Estimated completion is 2019-01.
What conditions does trial NCT02453113 study?
This clinical trial studies the following conditions: Vaccine Response Impaired.
What interventions are being tested in trial NCT02453113?
The interventions under investigation include: low power laser (OTHER).
Who is sponsoring clinical trial NCT02453113?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02453113 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccine Response Impaired
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02453113's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia